Title: Efficacy of Lamivudine in Treating Chronic Serious-type Hepatitis
Abstract: Objective: To study the efficacy, safety and effect to prognosis of Lamivudine in treating the chronic and fulminant virus hepatitis B patients. Methods: Oral Lamivudine tablet 100mg/d×30d with regular treatment were used to treat the chronic and fulminant virus hepatitis Bpatients and compared with the control group. Results: The efficacy rate of the group treated with Lamivudine (75% ) was higher than the control group (53%). P0.05, without the obvious adverse reaction. Conducsions:The study shows that in consideration of lack of specific treatment now to the chronic and fulminant virus hepatitis B, it is a relatively good choice to treat with Lamivudine associated with the regular regular treatment. It can raise the rate of survival.
Publication Year: 2002
Publication Date: 2002-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot